Nano dialogue
June 16, 2011
THE US Food and Drug
Administration is set to publish
a series of proposed
guidelines on how it will
identify whether nanomaterials
have been used in FDAregulated
products.
Titled Draft Guidance for
Industry, Considering Whether an
FDA-Regulated Product Involves
the Application of Nanotechnology,
the guidance is said to provide
a starting point for
nanotechnology discussion.
“Our goal is to regulate these
products using the best possible
science,” said FDA Commissioner
Margaret Hamburg.
“Understanding
nanotechnology remains a top
priority within the agency’s
regulatory science initiative
and, in doing so, we will be
prepared to usher science,
public health, and FDA into a
new, more innovative era,” she
added.
In the lead-up to the release,
the FDA is calling for comment
from both industry leaders and
the general public.
See www.fda.gov for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jun 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jun 11
